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Abstract
Hepatitis C virus (HCV) is an RNA virus that preferentially infects hepatocytes and is transmitted through infected
blood contact. Chronic hepatitis C can result in serious life-threatening conditions like ﬁbrosis, cirrhosis, and liver
cancer. Additionally, it can result in extrahepatic conditions including lymphoproliferative disease and mixed cryoglobulinemic vasculitis.
Mixed cryoglobulinemic vasculitis occurs as a result of immune system dysfunction leading to immunoglobulin
deposits into different blood vessels in the body. The main manifestations commonly seen are purpura, weakness,
arthralgias. Other symptoms include peripheral neuropathy, arthritis, vasculitic skin ulcers, liver, and renal involvement.
This case highlights a 57-year-old male with a medical history of substance use disorder, bilateral lower extremity
ulcers, and chronic hepatitis C infection who presented with complaints of bilateral lower extremity wounds, abdominal
distension, and scrotal swelling.
Our patient was conﬁrmed to have new-onset cirrhotic liver secondary to intravenous drug use, with worsening renal
function. Further investigations conﬁrmed the diagnosis of mixed cryoglobulinemia secondary to hepatitis C virus.
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1. Introduction

C

hronic Hepatitis C infection has been strongly
linked and associated with glomerular diseases.
Some of these diseases include mixed cryoglobulinemia, membranoproliferative glomerulonephritis (MPGN), membranous nephropathy, and
polyarteritis nodosa (PAN). One of the major diseases
associated with HCV infection is mixed cryoglobulinemia. Most patients with mixed cryoglobulinemia tend to have HCV infection, with
evidence suggesting that HCV-containing immune
complexes are responsible for the pathogenesis of this
disease. Our case report highlights a patient with a
chronic history of HCV and developed mixed
cryoglobulinemia.

2. Case presentation
A 57-year-old male with a past medical history of
substance use disorder, bilateral lower extremity

ulcers, chronic hepatitis C infection for 6 years, and
poor compliance with medical care presented to the
ED with complaints of abdominal distention and
scrotal swelling. The patient reported that symptoms
started two weeks before his presentation and had
progressively worsened. Patient also complained of
bilateral non-healing lower extremity wounds which
he had for a year. In terms of the hepatitis C, it was
diagnosed six years prior to this presentation. Patient
denied being on any treatment plan, with no adequate
follow up with any physician. On examination, the
abdomen was grossly distended with positive ﬂuid
wave, suggesting ascites. There was a 3þ pitting
edema extending from the scrotum to the bilateral
lower extremity ulcers with draining a foul-smelling
purulent discharge. The lower extremity ulcers had
sparce open lesions each noted to be superﬁcial with
ﬁbro-granular wound beds, with mild odor, and serous discharge noted.
Initial vital signs revealed a temperature of 98.7 F,
BP 129/70 mmHg, Pulse 71 bpm, RR 18 breaths per
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minute with oxygen saturation of 100%. Labs
revealed hemoglobin of 12.1 g/dl (Normal: 12e16 g/
dl) with platelet count of 78 K (Normal: 130e400 K).
Urinalysis revealed large blood with 0e2 RBCs,
negative nitrite, trace leukocyte esterase with 0e2
WBCs, and 100 mg/dl protein. A repeat urinalysis
revealed large blood with 2e4 RBCs, positive nitrite,
trace leukocyte esterase with 0e2 WBCs, and
>300 mg/dl protein. CMP showed creatinine of
4.3 mg/dl with a baseline creatinine of 0.8 mg/dl a
year prior, and BUN 55 mg/dl. A CT abdomen and
pelvis conﬁrmed a new-onset cirrhotic liver with
abdominal ascites (See Fig. 1). A hepatitis panel was
ordered, and it was negative for hepatitis A, and B,
but positive for Hepatitis C virus. HIV was also
negative. The patient was started on Furosemide,
Octreotide, and Nadolol. He also received antibiotics and his wounds were managed.
The next day, the patient developed leukopenia
with WBC of 4.5, with worsening hemoglobin and
platelet count of 11.1 g/dl and 47  109/L respectively. His renal function continued to worsen with
creatinine 4.76 mg/dl, and BUN 63 mg/dl. Patient
underwent ultrasound-guided paracentesis, with
1.5 L of ﬂuid removed. A renal ultrasound was
performed which showed nonspeciﬁc increased
echogenicity. His ascites and lower extremity ulcers
improved signiﬁcantly on the treatment regimen
however, renal function continued to decline
precipitously.
Given worsening renal function and cirrhosis, a
possible diagnosis of the hepatorenal syndrome was
made. Patient was started on Albumin infusion with
no signiﬁcant improvement in renal function.
Hence, the nephrology team was consulted, and a
renal biopsy was recommended. Patient was started
on dialysis and the renal biopsy was subsequently
performed.

Renal biopsy results showed mild focal mesangial
proliferative glomerulonephritis with co-dominant
deposits of IgA and C3. Serum complement levels
were also low with C3 of 66 (normal: 82e185), C4 count
of 11 (normal: 15e53), and low total complement levels
<10 (normal: 31e60). Patient had HCV viral load count
of 156,000 IU/mL and HCV genotype of 1a. Serum
cryoglobulin levels were ordered, but due to a lab
error it was not resulted. These ﬁndings, together with
the patient's clinical presentation, suggested a picture
of mixed cryoglobulinemia secondary to HCV over
hepatorenal syndrome as the cause of the patient's
presenting symptoms. Patient was managed with
Methylprednisone 1 g IV for 3 days and discharged
with a plan for outpatient hemodialysis three times
per week, as well as outpatient gastroenterology
follow up to initiate Hepatitis C virus treatment. Patient was also encouraged to follow up outpatient to
start treatment with Rituximab.
After being discharged from the hospital, patient
was noted to have followed up with his dialysis
appointments. We also scheduled the patient with
our medicine clinic for a visit. Prior to the scheduled
time of his clinic visit, the patient was called to
conﬁrm his appointment by a clinic staff. A family
member responded to the call and conﬁrmed that
the patient passed away due to suspicions of drug
overdose.

3. Discussion
Cryoglobulinemia refers to the presence of proteins or cryoglobulins in the blood. They are immunoglobulins that are known to precipitate at low
temperatures (below 37C) and redissolve on
rewarming. They are usually classiﬁed into 3 types;
Type 1 which causes hyper viscosity from levels of
single
monoclonal
cryoglobulin
due
to

Fig. 1. CT Abdomen: Showing cirrhotic liver with abdominal ascites.
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Table 1. Classiﬁcation of Mixed Cryoglobulinemia.
Criteria

Major

Minor

Serologic

Mixed cryoglobulins
Low C4

Pathologic
Clinical

Leukocytoclastic vasculitis
Purpura

Rheumatoid factor
HCVþ
HBVþ
Clonal B-cell inﬁltrates (liver or bone marrow)
Chronic hepatitis
Membranoproliferative glomerulonephritis
Peripheral neuropathy
Skin ulcers

lymphoproliferative disorders, and type II and III,
which are referred to as mixed cryoglobulins, and
can be as a result from chronic hepatitis C or connective tissue disorders.1
Mixed cryoglobulinemia refers to cryoglobulins in
the serum that contain more than one immunological
component.2 The main symptoms seen in mixed
cryoglobulinemia includes purpura, weakness, arthralgias, also known as the Meltzer's triad. Other
features could include peripheral neuropathy,
Raynaud's phenomenon, arthritis, vasculitic skin ulcers, liver and renal involvement.2 In terms of
diagnosing this, light microscopy will show a membranoproliferative pattern of injury which is secondary to the deposition of immune complexes. Electron
microscopy highlights endocapillary proliferation
with subendothelial deposits, and immunoﬂuorescence will show depositions of immunoglobulins
such as IgM, IgG, and C3.3 Our patient was seen to
have weakness, purpura, skin ulcers, with both
pathological liver and renal involvement.
Several studies have shown a possible relationship between HCV and mixed cryoglobulinemia, yet
the potential role and pathogenesis on how these
conditions are associated has not been fully studied.
Thus, concluding information are yet to be made on
this topic.4 According to a study done by Lunel et al.,
they reported a higher prevalence of mixed cryoglobulinemia in France in HCV positive patients,
which was associated with a long history of hepatitis
and the presence of liver cirrhosis.5 Just as in this
case presented, our patient was diagnosed with
Hepatitis C at least 10 years before presenting with
mixed cryoglobulinemia.
Diagnosing mixed cryoglobulinemia depends on
both clinical and laboratory ﬁndings. Laboratory
ﬁndings should include cryoglobulin testing, total
serum protein and immunoglobulins, complement
levels, virologic markers such as hepatitis panel,
blood chemistry and urinalysis. The Italian Group
for the Study of Cryoglobulinemia proposed a set of
criteria necessary for diagnosing and classifying
mixed cryoglobulinemia6 (see Table 1).
Mixed cryoglobulinemia (MC) can be managed
with immunosuppressive drugs, steroids, and

plasmapheresis, but these therapies are ineffective
in allowing for long-term remission. Interferon a
(INF-a) is the choice drug for managing MC, and
this shows an indirect proof between the association
of mixed cryoglobulinemia with hepatis C virus
infection, and the results of IFN treatment in MC
patients represent an indirect proof for the pathogenetic link between MC and HCV infection.7
In addition to treating the associated underlying
disease (when present), patients who have one or
more of these manifestations should be treated with
immunosuppressive therapy to rapidly improve or
resolve target-organ damage, rather than therapy
directed at the underlying etiology alone. Immunosuppressive therapy usually combines a short
course of glucocorticoids with rituximab and, in
selected patients, plasmapheresis.1 Our goal with
our patient is to have him follow up with the
required specialist outpatient to start him on the
right therapy to improve his health. While a relationship can be seen between hepatitis C, membranous
glomerulonephritis
and
mixed
cryoglobulinemia, more studies need to be done to
prove a causal relationship.

4. Conclusion
This case illustrates a rare cause of systemic organ
damage and particularly, renal function loss in patients with chronic hepatitis C infection. A high
degree of suspicion and early treatment could prevent permanent kidney damage and lifelong
hemodialysis.
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